The expression pattern, genetic alteration, prognostic relevance, and immunological association of RAR-α in different BC tissues were assessed using the TIMER 2.0, UCSC XENA, Bc GeneExminer, ENRICHR, TISCH, UALCAN, KM-Plotter and Oncomine tools. This evidence concerns the gene RARA and breast cancer.